Literature DB >> 20029200

MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction.

Emanuela Bostjancic1, Nina Zidar, Dusan Stajer, Damjan Glavac.   

Abstract

OBJECTIVES: MicroRNAs (miRNAs) are noncoding single-stranded RNA molecules that regulate gene expression in physiological functions, development and disease. In recent studies, three miRNAs have been described as muscle or cardiac specific: miR-1, miR-133, and miR-208, being involved in heart development and disease; but there are limited data on their role in human myocardial infarction (MI). We therefore analyzed their expression in human MI.
METHODS: Autopsy samples of infarcted heart tissue from 50 patients with MI, 8 healthy trauma victims and 9 fetuses that died in utero were included. miRNAs miR-1, miR-133a/b and miR-208 were analyzed using quantitative real-time polymerase chain reaction.
RESULTS: miR-208 was upregulated, whereas miR-1 and miR-133a were downregulated in MI compared to healthy adult and fetal hearts. All four tested miRNAs were downregulated in fetal hearts compared to healthy adult hearts.
CONCLUSIONS: Our study showed the involvement of muscle- and/or cardiac-specific miRNAs miR-1, miR-133a/b and miR-208 in human MI. The most significant finding was upregulation of miR-208 and downregulation of miR-1 and miR-133a in MI compared to healthy adult hearts. Some patterns of miRNA expression were similar in MI and fetal hearts, supporting the concept of cardiac gene reprogramming in the remodeling of the heart.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20029200     DOI: 10.1159/000268088

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  135 in total

1.  MicroRNA profiling predicts a variance in the proliferative potential of cardiac progenitor cells derived from neonatal and adult murine hearts.

Authors:  Padmini Sirish; Javier E López; Ning Li; Andrew Wong; Valeriy Timofeyev; J Nilas Young; Maryam Majdi; Ronald A Li; Huei-Sheng Vincent Chen; Nipavan Chiamvimonvat
Journal:  J Mol Cell Cardiol       Date:  2011-10-20       Impact factor: 5.000

Review 2.  MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker.

Authors:  Ying Huang; Jun Li
Journal:  J Physiol Biochem       Date:  2015-04-04       Impact factor: 4.158

Review 3.  Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.

Authors:  Feng Wang; Chen Chen; Daowen Wang
Journal:  Front Med       Date:  2014-12-01       Impact factor: 4.592

Review 4.  microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.

Authors:  Christian Schulte; Tanja Zeller
Journal:  Cardiovasc Diagn Ther       Date:  2015-02

Review 5.  Implications for MicroRNA involvement in the prognosis and treatment of atherosclerosis.

Authors:  Samira Tabaei; Seyyedeh Samaneh Tabaee
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

6.  Improved knee extensor strength with resistance training associates with muscle specific miRNAs in older adults.

Authors:  Tan Zhang; Alexander Birbrair; Zhong-Min Wang; María L Messi; Anthony P Marsh; Iris Leng; Barbara J Nicklas; Osvaldo Delbono
Journal:  Exp Gerontol       Date:  2015-01-02       Impact factor: 4.032

Review 7.  MicroRNAs in injury and repair.

Authors:  Cory V Gerlach; Vishal S Vaidya
Journal:  Arch Toxicol       Date:  2017-05-13       Impact factor: 5.153

Review 8.  MicroRNAs: new players in cardiac injury and protection.

Authors:  Rakesh C Kukreja; Chang Yin; Fadi N Salloum
Journal:  Mol Pharmacol       Date:  2011-07-07       Impact factor: 4.436

9.  Feedback mechanisms for cardiac-specific microRNAs and cAMP signaling in electrical remodeling.

Authors:  Richard Myers; Valeriy Timofeyev; Ning Li; Catherine Kim; Hannah A Ledford; Padmini Sirish; Victor Lau; Yinuo Zhang; Kiran Fayyaz; Anil Singapuri; Javier E Lopez; Anne A Knowlton; Xiao-Dong Zhang; Nipavan Chiamvimonvat
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-05-20

Review 10.  MicroRNAs as biomarkers for ischemic heart disease.

Authors:  Lucas N L Van Aelst; Stephane Heymans
Journal:  J Cardiovasc Transl Res       Date:  2013-05-29       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.